Clinical Trial Update: Immunity to Infection in Healthy Participants and Participants With Cancer

View source ↗

Summary

This clinical trial update describes an ongoing study evaluating immunity to influenza and COVID-19 in healthy participants and in patients with cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Tumor

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Influenza, SARS-CoV-2 | Status: ACTIVE_NOT_RECRUITING